ATCT-15 CB-018: A PHASE 2 TRIAL OF BEVACIZUMAB PLUS TPI 287, A NOVEL BRAIN PENETRABLE ANTI-MICROTUBULE AGENT, IN PATIENTS WITH RECURRENT GLIOBLASTOMA FOLLOWING PROGRESSION ON ANTI-ANGIOGENIC THERAPY

Gardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Main Authors: Goldlust, Samuel, Nabors, L. Burt, Sahebjam, Solmaz, Hsu, Sigmund, Mohile, Nimish, Benkers, Tara, Giglio, Pierre, Raizer, Jeffrey, Silberman, Sandra, Kumthekar, Priya, Singer, Samuel, Farmer, George
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2015
Assuntos:
Abstracts from the 20th Annual Scientific Meeting of the Society for Neuro-Oncology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4638566/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nov206.15
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares